Paper157372
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.
Reinherz EL and 3 others. J Immunol, 1979. Cited by 521 papers, by iCite.
Cite this record
ConductScience Library. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. Papers, record 157372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/157372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Leukemia, Lymphoid | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Line | |
| Cell Separation | |
| Classification | |
| Clone Cells | |
| Female | |
| Fluorescent Antibody Technique | |
| Humans | |
| Hybrid Cells | |
| Lymphocyte Culture Test, Mixed | |
| Lymphocytes | |
| Mice | |
| Neoplasms, Experimental |
Source PubMed
Cited by129
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 521 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40963254 | Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infections. | Mol Ther | 2025 | https://conductscience.org/library/papers/40963254 | PubMed |
| 40882634 | Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40882634 | PubMed |
| 33287301 | Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. | Cells | 2020 | https://conductscience.org/library/papers/33287301 | PubMed |
| 31884955 | Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/31884955 | PubMed |
| 25237383 | Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation. | AIDS Res Ther | 2014 | https://conductscience.org/library/papers/25237383 | PubMed |
| 23105463 | Enumeration of lymphocyte subsets using flow cytometry: Effect of storage before and after staining in a developing country setting. | Indian J Clin Biochem | 2004 | https://conductscience.org/library/papers/23105463 | PubMed |
| 12390042 | Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients. | Paediatr Drugs | 2002 | https://conductscience.org/library/papers/12390042 | PubMed |
| 8881760 | Preparation of monoclonal anti-porcine CD3 antibodies and preliminary characterization of porcine T lymphocytes. | Immunology | 1996 | https://conductscience.org/library/papers/8881760 | PubMed |
| 8879199 | CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. | J Exp Med | 1996 | https://conductscience.org/library/papers/8879199 | PubMed |
| 8418199 | Putative prethymic T cell precursors within the early human embryonic liver: a molecular and functional analysis. | J Exp Med | 1993 | https://conductscience.org/library/papers/8418199 | PubMed |
| 7839069 | Defective mitogen-induced cellular cytotoxicity in untreated patients with active rheumatoid arthritis. | Rheumatol Int | 1994 | https://conductscience.org/library/papers/7839069 | PubMed |
| 7682894 | In vitro and in vivo properties of an anti-CD5-momordin immunotoxin on normal and neoplastic T lymphocytes. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/7682894 | PubMed |
| 7518803 | Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. | Immunogenetics | 1994 | https://conductscience.org/library/papers/7518803 | PubMed |
| 7513045 | The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/7513045 | PubMed |
| 7047568 | Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7047568 | PubMed |
| 7039881 | Enumeration of T and B lymphocytes in whole peripheral blood: absence of a null cell population. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7039881 | PubMed |
| 7028788 | Reactivity of a monoclonal antibody with human ovarian carcinoma. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7028788 | PubMed |
| 7015346 | Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/7015346 | PubMed |
| 7000827 | Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7000827 | PubMed |
| 6988098 | The T lymphoblastic malignancies. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6988098 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/157372
GET https://conductscience.org/api/papers/v1/157372/cited_by?page=2